8-K

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                    FORM 8-K


                                 CURRENT REPORT


                     PURSUANT TO SECTION 13 OR 15(D) OF THE
                         SECURITIES EXCHANGE ACT OF 1934


 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): JUNE 29, 2006 (JUNE 26, 2006)


                      ALLIED HEALTHCARE INTERNATIONAL INC.
      --------------------------------------------------------------------
             (EXACT NAME OF REGISTRANT AS SPECIFIED ON ITS CHARTER)





            1-11570                                                    13-3098275
- ----------------------------------                   ------------------------------------------------
     (COMMISSION FILE NUMBER)                              (IRS EMPLOYER IDENTIFICATION NUMBER)



                                    NEW YORK
 ------------------------------------------------------------------------------
         (STATE OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZATION)


                  555 MADISON AVENUE, NEW YORK, NEW YORK 10022
   ---------------------------------------------------------------------------
                    (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)


                                 (212) 750-0064
 ---------------------------------------------------------------------------------
              (REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE)



 ---------------------------------------------------------------------------------
          (FORMER NAME OR FORMER ADDRESS, IF CHANGED SINCE LAST REPORT)

CHECK THE APPROPRIATE BOX BELOW IF THE FORM 8-K FILING IS INTENDED TO
SIMULTANEOUSLY SATISFY THE FILING OBLIGATION OF THE REGISTRANT UNDER ANY OF THE
FOLLOWING PROVISION:

    ___    WRITTEN COMMUNICATIONS PURSUANT TO RULE 425 UNDER THE SECURITIES ACT.
    ___    SOLICITING MATERIAL PURSUANT TO RULE 14A-12 UNDER THE EXCHANGE ACT.
    ___    PRE-COMMENCEMENT COMMUNICATIONS PURSUANT TO RULE 14D-2(B) UNDER THE
           EXCHANGE ACT.
    ___    PRE-COMMENCEMENT COMMUNICATIONS PURSUANT TO RULE 13E-4(C) UNDER THE
           EXCHANGE ACT.






ITEM 5.02.  DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS;
            APPOINTMENT OF PRINCIPAL OFFICERS.

         On June 26, 2006, Charles F. Murphy resigned as Chief Financial Officer
of Allied Healthcare International Inc. (the "Company"). Mr. Murphy has agreed
to remain with the Company on a transition basis through September 30, 2006.

         Paul D.J. Weston, age 41, will act as interim Chief Financial Officer
of the Company, effective as of June 26, 2006. Pursuant to his employment
agreement with Allied Healthcare (UK) Limited, a subsidiary of the Company now
known as Allied Healthcare Group Ltd., Mr. Weston's salary is (pound)136,500 per
annum (approximately $247,500 at current exchange levels) and prohibits him from
competing with the Company or its subsidiaries for a period of six months
following termination of employment.

         Paul D.J. Weston has been employed by the Company since 2004, serving
as the Company's Financial Director in the U.K. since 2005 and, as such, has
been responsible for all the Company's U.K. operating subsidiaries. From 2001 to
2004, Mr. Weston was Group Financial Controller at SSL plc, a global
manufacturer and distributor of healthcare products, and prior to that he spent
seven years in various corporate finance positions for the European operations
of Fruit of the Loom, a textile manufacturer. Mr. Weston qualified with the
Institute of Chartered Accountants (ACA) in 1990.

         Mr. Weston has previously been granted options to purchase an aggregate
of 22,000 shares of common stock of the Company at an average weighted exercise
price of $5.95 per share.

ITEM 9.01   FINANCIAL STATEMENTS AND EXHIBITS.

     99.1   Press release, dated June 26, 2006, of Allied Healthcare
            International Inc.







                                   SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Dated:  June 29, 2006

                            ALLIED HEALTHCARE INTERNATIONAL INC.


                            By:        /s/ Marvet Abbassi
                                     -------------------------------------------
                                     Name:  Marvet Abbassi
                                     Title: Financial Controller

EX-99.1

                                                                    Exhibit 99.1

       Allied Healthcare International Inc. Promotes Paul D.J. Weston to
                         Acting Chief Financial Officer

   NEW YORK--June 26, 2006--Allied Healthcare International Inc.
(Nasdaq: AHCI) (AIM: AHI) announces that Paul D.J. Weston will be
acting as interim Chief Financial Officer, replacing Charles F.
Murphy, who has resigned, effective June 26, 2006.

   Mr. Weston, 41 years old, has served as the Company's Financial
Director in the U.K. since 2005 and, as such, has been responsible for
all the U.K. operating subsidiaries. Previously, from 2001 to 2004,
Mr. Weston was Group Financial Controller at SSL plc, and prior to
that he spent seven years in various corporate finance positions for
the European operations of Fruit of the Loom. Mr. Weston qualified
with the Institute of Chartered Accountants (ACA) in 1990.

                   ABOUT ALLIED HEALTHCARE INTERNATIONAL INC.

    Allied Healthcare International Inc. (http://www.alliedhealthcare.com) is a
leading provider of flexible healthcare staffing services in the United Kingdom.
Allied operates a community-based network of approximately 100 branches with the
capacity to provide carers (known as home health aides in the U.S.), nurses, and
specialized medical personnel to locations covering approximately 90% of the
U.K. population. Allied meets the needs of Private Patients, Community Care,
Nursing Homes and Hospitals. The company also supplies medical-grade oxygen for
use in respiratory therapy to the U.K. pharmacy market and Northern Ireland and
oxygen concentrators to customers in Northern Ireland. Following the award of
the new oxygen contracts, the Company now also provides unified oxygen services
directly to customers in the South East of England.

    CONTACT: The Investor Relations Group
             Adam Holdsworth, 212-825-3210